Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of bile acid biosynthetic process (GO:0070857) | 8.29228070 |
2 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 8.11292097 |
3 | bile acid and bile salt transport (GO:0015721) | 8.08717688 |
4 | adhesion of symbiont to host cell (GO:0044650) | 7.42345263 |
5 | virion attachment to host cell (GO:0019062) | 7.42345263 |
6 | regulation of guanylate cyclase activity (GO:0031282) | 7.34953854 |
7 | NADH metabolic process (GO:0006734) | 7.21234110 |
8 | actin filament depolymerization (GO:0030042) | 6.72933411 |
9 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.43087613 |
10 | epoxygenase P450 pathway (GO:0019373) | 6.30172657 |
11 | adhesion of symbiont to host (GO:0044406) | 6.01496762 |
12 | fructose metabolic process (GO:0006000) | 5.57624396 |
13 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.52811369 |
14 | digestive system process (GO:0022600) | 5.52208393 |
15 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.51171851 |
16 | modified amino acid transport (GO:0072337) | 5.38433257 |
17 | vitamin A metabolic process (GO:0006776) | 5.35306323 |
18 | drug catabolic process (GO:0042737) | 5.35269667 |
19 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 5.28338633 |
20 | response to hepatocyte growth factor (GO:0035728) | 5.28338633 |
21 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 5.26387890 |
22 | defense response to fungus (GO:0050832) | 5.16795226 |
23 | killing of cells of other organism (GO:0031640) | 5.11680435 |
24 | disruption of cells of other organism (GO:0044364) | 5.11680435 |
25 | glucose 6-phosphate metabolic process (GO:0051156) | 4.90097473 |
26 | regulation of triglyceride catabolic process (GO:0010896) | 4.88314236 |
27 | peptide hormone processing (GO:0016486) | 4.83752718 |
28 | lipoprotein metabolic process (GO:0042157) | 4.82827519 |
29 | drinking behavior (GO:0042756) | 4.80717455 |
30 | regulation of cellular extravasation (GO:0002691) | 4.74816092 |
31 | drug metabolic process (GO:0017144) | 4.67995731 |
32 | regulation of cGMP biosynthetic process (GO:0030826) | 4.66501712 |
33 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.60908494 |
34 | lipoprotein transport (GO:0042953) | 4.58469949 |
35 | thyroid hormone metabolic process (GO:0042403) | 4.56344812 |
36 | antibacterial humoral response (GO:0019731) | 4.55006374 |
37 | sulfate transmembrane transport (GO:1902358) | 4.53614671 |
38 | antimicrobial humoral response (GO:0019730) | 4.48318178 |
39 | sulfur compound transport (GO:0072348) | 4.41970115 |
40 | diacylglycerol metabolic process (GO:0046339) | 4.29708958 |
41 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 4.26261401 |
42 | plasma lipoprotein particle assembly (GO:0034377) | 4.25480486 |
43 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.21189764 |
44 | digestion (GO:0007586) | 4.20491750 |
45 | protein-lipid complex assembly (GO:0065005) | 4.18987109 |
46 | regulation of cholesterol homeostasis (GO:2000188) | 4.12905123 |
47 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.06179134 |
48 | intestinal epithelial cell development (GO:0060576) | 4.05042131 |
49 | cellular response to nitric oxide (GO:0071732) | 3.95966683 |
50 | cholesterol homeostasis (GO:0042632) | 3.93969209 |
51 | renal system process involved in regulation of blood volume (GO:0001977) | 3.91245479 |
52 | urea cycle (GO:0000050) | 3.91006499 |
53 | sterol homeostasis (GO:0055092) | 3.90265973 |
54 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.89959079 |
55 | regulation of cGMP metabolic process (GO:0030823) | 3.83784758 |
56 | regulation of vitamin metabolic process (GO:0030656) | 3.82657927 |
57 | flavonoid metabolic process (GO:0009812) | 3.80019022 |
58 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.79457433 |
59 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.79457433 |
60 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.79404983 |
61 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.77985376 |
62 | cholesterol efflux (GO:0033344) | 3.75031949 |
63 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.73928511 |
64 | endocrine process (GO:0050886) | 3.73928511 |
65 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.73928511 |
66 | urea metabolic process (GO:0019627) | 3.72606955 |
67 | O-glycan processing (GO:0016266) | 3.72432719 |
68 | response to nitric oxide (GO:0071731) | 3.71400616 |
69 | cholesterol transport (GO:0030301) | 3.70139618 |
70 | sterol transport (GO:0015918) | 3.70139618 |
71 | sulfate transport (GO:0008272) | 3.67847109 |
72 | vitamin transmembrane transport (GO:0035461) | 3.67045089 |
73 | phospholipid efflux (GO:0033700) | 3.66081514 |
74 | glycolipid catabolic process (GO:0019377) | 3.63586349 |
75 | alkaloid metabolic process (GO:0009820) | 3.62069739 |
76 | regulation of actin nucleation (GO:0051125) | 3.61545748 |
77 | regulation of cholesterol esterification (GO:0010872) | 3.61169951 |
78 | negative regulation of sterol transport (GO:0032372) | 3.60964955 |
79 | negative regulation of cholesterol transport (GO:0032375) | 3.60964955 |
80 | glycosphingolipid catabolic process (GO:0046479) | 3.57791549 |
81 | nitrogen cycle metabolic process (GO:0071941) | 3.57595643 |
82 | neutral amino acid transport (GO:0015804) | 3.52879516 |
83 | uronic acid metabolic process (GO:0006063) | 3.49832782 |
84 | glucuronate metabolic process (GO:0019585) | 3.49832782 |
85 | cellular response to reactive nitrogen species (GO:1902170) | 3.47992004 |
86 | peptide catabolic process (GO:0043171) | 3.47216239 |
87 | cellular glucuronidation (GO:0052695) | 3.43270327 |
88 | hormone catabolic process (GO:0042447) | 3.43063982 |
89 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.40278408 |
90 | hepatocyte apoptotic process (GO:0097284) | 3.39883443 |
91 | leukotriene metabolic process (GO:0006691) | 3.39463950 |
92 | negative regulation of sodium ion transport (GO:0010766) | 3.39289864 |
93 | epithelial structure maintenance (GO:0010669) | 3.37881899 |
94 | cGMP biosynthetic process (GO:0006182) | 3.37096779 |
95 | phospholipid homeostasis (GO:0055091) | 3.36303649 |
96 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.35150396 |
97 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.35150396 |
98 | negative regulation of steroid biosynthetic process (GO:0010894) | 3.34018837 |
99 | transepithelial transport (GO:0070633) | 3.29620957 |
100 | regulation of systemic arterial blood pressure (GO:0003073) | 3.29343913 |
101 | L-ascorbic acid metabolic process (GO:0019852) | 3.26562209 |
102 | fat-soluble vitamin metabolic process (GO:0006775) | 3.22022848 |
103 | striated muscle atrophy (GO:0014891) | 3.21053315 |
104 | negative regulation of steroid metabolic process (GO:0045939) | 3.19816993 |
105 | homocysteine metabolic process (GO:0050667) | 3.18359981 |
106 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.17130703 |
107 | thrombin receptor signaling pathway (GO:0070493) | 3.16622964 |
108 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.15438371 |
109 | response to histamine (GO:0034776) | 3.14462265 |
110 | hydrogen peroxide catabolic process (GO:0042744) | 3.14222875 |
111 | hemidesmosome assembly (GO:0031581) | 3.12435950 |
112 | positive regulation of pseudopodium assembly (GO:0031274) | 3.10960136 |
113 | negative regulation of digestive system process (GO:0060457) | 3.10585927 |
114 | quinone biosynthetic process (GO:1901663) | 3.08924699 |
115 | filopodium assembly (GO:0046847) | 3.07758304 |
116 | vitamin biosynthetic process (GO:0009110) | 3.07089799 |
117 | transcytosis (GO:0045056) | 3.06580084 |
118 | exogenous drug catabolic process (GO:0042738) | 3.05648029 |
119 | hydrogen peroxide metabolic process (GO:0042743) | 3.04986737 |
120 | cytidine deamination (GO:0009972) | 3.04685158 |
121 | cytidine metabolic process (GO:0046087) | 3.04685158 |
122 | cytidine catabolic process (GO:0006216) | 3.04685158 |
123 | thyroid hormone generation (GO:0006590) | 3.04119542 |
124 | cobalamin metabolic process (GO:0009235) | 3.03794116 |
125 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.03203303 |
126 | response to fungus (GO:0009620) | 3.01579395 |
127 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.00592116 |
128 | sexual reproduction (GO:0019953) | 2.98930192 |
129 | plasma lipoprotein particle organization (GO:0071827) | 2.96914804 |
130 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.96697126 |
131 | monocarboxylic acid transport (GO:0015718) | 2.95954018 |
132 | arachidonic acid metabolic process (GO:0019369) | 2.95112786 |
133 | glycerol metabolic process (GO:0006071) | 2.94698992 |
134 | protein kinase C signaling (GO:0070528) | 2.92521631 |
135 | phenol-containing compound catabolic process (GO:0019336) | 2.92436473 |
136 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.92408684 |
137 | high-density lipoprotein particle remodeling (GO:0034375) | 2.92367517 |
138 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.91151846 |
139 | positive regulation of cGMP metabolic process (GO:0030825) | 2.90696176 |
140 | protein-lipid complex remodeling (GO:0034368) | 2.90212951 |
141 | macromolecular complex remodeling (GO:0034367) | 2.90212951 |
142 | plasma lipoprotein particle remodeling (GO:0034369) | 2.90212951 |
143 | regulation of viral release from host cell (GO:1902186) | 2.88816877 |
144 | positive regulation of lipid catabolic process (GO:0050996) | 2.88056784 |
145 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.87828032 |
146 | ceramide catabolic process (GO:0046514) | 2.87728467 |
147 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.86170148 |
148 | bile acid metabolic process (GO:0008206) | 2.84187572 |
149 | bicarbonate transport (GO:0015701) | 2.81484406 |
150 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.81357227 |
151 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.80941627 |
152 | lipid homeostasis (GO:0055088) | 2.77732771 |
153 | skeletal muscle adaptation (GO:0043501) | 2.76864690 |
154 | sperm capacitation (GO:0048240) | 2.76650123 |
155 | vitamin transport (GO:0051180) | 2.75514455 |
156 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.73083140 |
157 | renal absorption (GO:0070293) | 2.69406084 |
158 | drug transport (GO:0015893) | 2.67558346 |
159 | sphingomyelin metabolic process (GO:0006684) | 2.65551622 |
160 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.65424311 |
161 | intestinal cholesterol absorption (GO:0030299) | 13.5709106 |
162 | angiotensin maturation (GO:0002003) | 12.7632292 |
163 | intestinal absorption (GO:0050892) | 12.3717517 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.12751207 |
2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.74471781 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.82523147 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.25298985 |
5 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.56998205 |
6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.17299690 |
7 | GATA6_25053715_ChIP-Seq_YYC3_Human | 3.00237635 |
8 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.91337385 |
9 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.80843587 |
10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.58636445 |
11 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.53323149 |
12 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.46170327 |
13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.28374079 |
14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.20486435 |
15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.11338882 |
16 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.08202436 |
17 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.00227396 |
18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.92036562 |
19 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.91113339 |
20 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.86945749 |
21 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.85109790 |
22 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.83092348 |
23 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.80431063 |
24 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.78981108 |
25 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.78922907 |
26 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.75163928 |
27 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.74400448 |
28 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.72854045 |
29 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.72034061 |
30 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.71313740 |
31 | GATA2_19941826_ChIP-Seq_K562_Human | 1.68948938 |
32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.67968414 |
33 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.63235876 |
34 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.63152097 |
35 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.62845167 |
36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.61370451 |
37 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.60950030 |
38 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.60840472 |
39 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.60506418 |
40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.58549540 |
41 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.58265618 |
42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.57082097 |
43 | ATF3_27146783_Chip-Seq_COLON_Human | 1.54209713 |
44 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.53430080 |
45 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.50659752 |
46 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.50087681 |
47 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.49404225 |
48 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.47415541 |
49 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.46899741 |
50 | SA1_27219007_Chip-Seq_Bcells_Human | 1.45678050 |
51 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41976053 |
52 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.41363503 |
53 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.40737605 |
54 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.40236647 |
55 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40025457 |
56 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.39795623 |
57 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.39623475 |
58 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39208126 |
59 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.38919934 |
60 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.37986539 |
61 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.37074057 |
62 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36975848 |
63 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.35043187 |
64 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34645969 |
65 | GATA1_19941826_ChIP-Seq_K562_Human | 1.33973985 |
66 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.31314715 |
67 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.28643975 |
68 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26591172 |
69 | UTX_26944678_Chip-Seq_JUKART_Human | 1.26161567 |
70 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.25949400 |
71 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.25802196 |
72 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.25756172 |
73 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25036813 |
74 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.24861130 |
75 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.24554964 |
76 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.22925072 |
77 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.21277878 |
78 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.19481618 |
79 | MYB_26560356_Chip-Seq_TH2_Human | 1.19349712 |
80 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19059293 |
81 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.18522335 |
82 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18505887 |
83 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.17848980 |
84 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17264382 |
85 | P300_27268052_Chip-Seq_Bcells_Human | 1.15862305 |
86 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.15599536 |
87 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15401227 |
88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15360308 |
89 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.13960723 |
90 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13563209 |
91 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13485187 |
92 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.13463597 |
93 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.13431537 |
94 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.11967346 |
95 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.11921305 |
96 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11360514 |
97 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.11163588 |
98 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.10963389 |
99 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.10591143 |
100 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.10187200 |
101 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.09913791 |
102 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.09474864 |
103 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.09145263 |
104 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.09089561 |
105 | * P68_20966046_ChIP-Seq_HELA_Human | 1.08819956 |
106 | MYB_26560356_Chip-Seq_TH1_Human | 1.07195339 |
107 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07180763 |
108 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05733660 |
109 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.05325913 |
110 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05226242 |
111 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.04563527 |
112 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.03919638 |
113 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03875056 |
114 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03866443 |
115 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.02970175 |
116 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.01114863 |
117 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.00328173 |
118 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.00000104 |
119 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.99688926 |
120 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98875567 |
121 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.97962234 |
122 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.97586776 |
123 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97062290 |
124 | MAF_26560356_Chip-Seq_TH1_Human | 0.96850528 |
125 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.96722643 |
126 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95727939 |
127 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.95727939 |
128 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.94920625 |
129 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94595271 |
130 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94381407 |
131 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.94219464 |
132 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.93950217 |
133 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93716128 |
134 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93083903 |
135 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.91605146 |
136 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.90602067 |
137 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.89481798 |
138 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.88151692 |
139 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.85505441 |
140 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.84440615 |
141 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.83513703 |
142 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.82027274 |
143 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.80717361 |
144 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80484945 |
145 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.80266520 |
146 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.79827343 |
147 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.78510432 |
148 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.78041616 |
149 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.76426752 |
150 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.76201355 |
151 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.75927567 |
152 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75787919 |
153 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74820590 |
154 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.74473920 |
155 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.73854692 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001666_abnormal_nutrient_absorption | 5.60442790 |
2 | MP0004264_abnormal_extraembryonic_tissu | 4.47811939 |
3 | MP0005085_abnormal_gallbladder_physiolo | 4.10353180 |
4 | MP0003183_abnormal_peptide_metabolism | 4.00868487 |
5 | MP0010234_abnormal_vibrissa_follicle | 3.95981934 |
6 | MP0002139_abnormal_hepatobiliary_system | 2.89193648 |
7 | MP0005365_abnormal_bile_salt | 2.76882551 |
8 | MP0009840_abnormal_foam_cell | 2.66657878 |
9 | MP0000462_abnormal_digestive_system | 2.63705845 |
10 | MP0003866_abnormal_defecation | 2.57402130 |
11 | MP0003252_abnormal_bile_duct | 2.43325174 |
12 | MP0004147_increased_porphyrin_level | 2.42303163 |
13 | MP0010329_abnormal_lipoprotein_level | 2.33453170 |
14 | MP0002822_catalepsy | 2.24561854 |
15 | MP0002876_abnormal_thyroid_physiology | 2.19455837 |
16 | MP0010352_gastrointestinal_tract_polyps | 2.19162610 |
17 | MP0005084_abnormal_gallbladder_morpholo | 2.15932294 |
18 | MP0003705_abnormal_hypodermis_morpholog | 2.10658631 |
19 | MP0000537_abnormal_urethra_morphology | 2.07493641 |
20 | MP0000538_abnormal_urinary_bladder | 2.02003945 |
21 | MP0003878_abnormal_ear_physiology | 2.01277414 |
22 | MP0005377_hearing/vestibular/ear_phenot | 2.01277414 |
23 | MP0005360_urolithiasis | 10.9811313 |
24 | MP0008875_abnormal_xenobiotic_pharmacok | 1.80637872 |
25 | MP0005670_abnormal_white_adipose | 1.66365203 |
26 | MP0009379_abnormal_foot_pigmentation | 1.65716679 |
27 | MP0010155_abnormal_intestine_physiology | 1.64794425 |
28 | MP0003300_gastrointestinal_ulcer | 1.62982864 |
29 | MP0001873_stomach_inflammation | 1.62260369 |
30 | MP0001764_abnormal_homeostasis | 1.59211820 |
31 | MP0003191_abnormal_cellular_cholesterol | 1.53318137 |
32 | MP0001663_abnormal_digestive_system | 1.49377773 |
33 | MP0000477_abnormal_intestine_morphology | 1.48618881 |
34 | MP0001835_abnormal_antigen_presentation | 1.47934457 |
35 | MP0005381_digestive/alimentary_phenotyp | 1.46217578 |
36 | MP0004019_abnormal_vitamin_homeostasis | 1.43511699 |
37 | MP0003436_decreased_susceptibility_to | 1.41970989 |
38 | MP0001664_abnormal_digestion | 1.39777088 |
39 | MP0005448_abnormal_energy_balance | 1.35865190 |
40 | MP0000490_abnormal_crypts_of | 1.32770360 |
41 | MP0003718_maternal_effect | 1.32603966 |
42 | MP0003724_increased_susceptibility_to | 1.27292889 |
43 | MP0006054_spinal_hemorrhage | 1.25403023 |
44 | MP0002089_abnormal_postnatal_growth/wei | 1.25265158 |
45 | MP0001188_hyperpigmentation | 1.25112335 |
46 | MP0009785_altered_susceptibility_to | 1.24297805 |
47 | MP0003868_abnormal_feces_composition | 1.23013721 |
48 | MP0009643_abnormal_urine_homeostasis | 1.22428002 |
49 | MP0005025_abnormal_response_to | 1.19653268 |
50 | MP0002796_impaired_skin_barrier | 1.19071087 |
51 | MP0002396_abnormal_hematopoietic_system | 1.15670131 |
52 | MP0004270_analgesia | 1.14329681 |
53 | MP0003303_peritoneal_inflammation | 1.12903764 |
54 | MP0000465_gastrointestinal_hemorrhage | 1.12154499 |
55 | MP0005167_abnormal_blood-brain_barrier | 1.11647619 |
56 | MP0008469_abnormal_protein_level | 1.05445316 |
57 | MP0002254_reproductive_system_inflammat | 1.04859124 |
58 | MP0005535_abnormal_body_temperature | 1.03534888 |
59 | MP0005671_abnormal_response_to | 1.02433027 |
60 | MP0002971_abnormal_brown_adipose | 1.01614947 |
61 | MP0005332_abnormal_amino_acid | 1.01274352 |
62 | MP0009333_abnormal_splenocyte_physiolog | 1.00719290 |
63 | MP0000230_abnormal_systemic_arterial | 0.99487454 |
64 | MP0004782_abnormal_surfactant_physiolog | 0.97961396 |
65 | MP0001849_ear_inflammation | 0.97241598 |
66 | MP0002148_abnormal_hypersensitivity_rea | 0.94747727 |
67 | MP0000609_abnormal_liver_physiology | 0.94721932 |
68 | MP0001501_abnormal_sleep_pattern | 0.94695985 |
69 | MP0001800_abnormal_humoral_immune | 0.94216717 |
70 | MP0005310_abnormal_salivary_gland | 0.93757949 |
71 | MP0001790_abnormal_immune_system | 0.93660914 |
72 | MP0005387_immune_system_phenotype | 0.93660914 |
73 | MP0010678_abnormal_skin_adnexa | 0.93071852 |
74 | MP0005000_abnormal_immune_tolerance | 0.91008885 |
75 | MP0003806_abnormal_nucleotide_metabolis | 0.87824389 |
76 | MP0002118_abnormal_lipid_homeostasis | 0.87551844 |
77 | MP0001756_abnormal_urination | 0.87505045 |
78 | MP0004947_skin_inflammation | 0.85831422 |
79 | MP0002166_altered_tumor_susceptibility | 0.85741254 |
80 | MP0009764_decreased_sensitivity_to | 0.85498531 |
81 | MP0005501_abnormal_skin_physiology | 0.84221572 |
82 | MP0002419_abnormal_innate_immunity | 0.82440896 |
83 | MP0002723_abnormal_immune_serum | 0.82253802 |
84 | MP0006082_CNS_inflammation | 0.79459763 |
85 | MP0001819_abnormal_immune_cell | 0.78633507 |
86 | MP0000685_abnormal_immune_system | 0.77897961 |
87 | MP0002420_abnormal_adaptive_immunity | 0.77532813 |
88 | MP0005367_renal/urinary_system_phenotyp | 0.75940782 |
89 | MP0000516_abnormal_urinary_system | 0.75940782 |
90 | MP0002452_abnormal_antigen_presenting | 0.73955575 |
91 | MP0003453_abnormal_keratinocyte_physiol | 0.73188980 |
92 | MP0001533_abnormal_skeleton_physiology | 0.70628592 |
93 | MP0000249_abnormal_blood_vessel | 0.70505062 |
94 | MP0001765_abnormal_ion_homeostasis | 0.70423814 |
95 | MP0005666_abnormal_adipose_tissue | 0.70418709 |
96 | MP0002138_abnormal_hepatobiliary_system | 0.68916113 |
97 | MP0005166_decreased_susceptibility_to | 0.68734768 |
98 | MP0005334_abnormal_fat_pad | 0.67005769 |
99 | MP0003950_abnormal_plasma_membrane | 0.66356780 |
100 | MP0004043_abnormal_pH_regulation | 0.65989583 |
101 | MP0003283_abnormal_digestive_organ | 0.65119539 |
102 | MP0003763_abnormal_thymus_physiology | 0.64962118 |
103 | MP0008872_abnormal_physiological_respon | 0.64456531 |
104 | MP0005464_abnormal_platelet_physiology | 0.64140652 |
105 | MP0003938_abnormal_ear_development | 0.62393696 |
106 | MP0002098_abnormal_vibrissa_morphology | 0.62186853 |
107 | MP0005023_abnormal_wound_healing | 0.61921593 |
108 | MP0000716_abnormal_immune_system | 0.59877926 |
109 | MP0008260_abnormal_autophagy | 0.59537022 |
110 | MP0000015_abnormal_ear_pigmentation | 0.59388257 |
111 | MP0000467_abnormal_esophagus_morphology | 0.58300324 |
112 | MP0009384_cardiac_valve_regurgitation | 0.57108663 |
113 | MP0009053_abnormal_anal_canal | 0.56331129 |
114 | MP0002136_abnormal_kidney_physiology | 0.55309701 |
115 | MP0003879_abnormal_hair_cell | 0.54016721 |
116 | MP0000678_abnormal_parathyroid_gland | 0.52102378 |
117 | MP0001216_abnormal_epidermal_layer | 0.51953558 |
118 | MP0010307_abnormal_tumor_latency | 0.49752820 |
119 | MP0005451_abnormal_body_composition | 0.49729581 |
120 | MP0000604_amyloidosis | 0.48468426 |
121 | MP0005636_abnormal_mineral_homeostasis | 0.47896183 |
122 | MP0000470_abnormal_stomach_morphology | 0.47807708 |
123 | MP0000681_abnormal_thyroid_gland | 0.47788328 |
124 | MP0003329_amyloid_beta_deposits | 0.46658935 |
125 | MP0005319_abnormal_enzyme/_coenzyme | 0.46347876 |
126 | MP0009642_abnormal_blood_homeostasis | 0.45939708 |
127 | MP0005409_darkened_coat_color | 0.45490742 |
128 | MP0008873_increased_physiological_sensi | 0.42358807 |
129 | MP0001191_abnormal_skin_condition | 0.40862744 |
130 | MP0003315_abnormal_perineum_morphology | 0.40455224 |
131 | MP0005266_abnormal_metabolism | 0.40299338 |
132 | MP0000377_abnormal_hair_follicle | 0.39226783 |
133 | MP0009115_abnormal_fat_cell | 0.38979335 |
134 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.38033249 |
135 | MP0005076_abnormal_cell_differentiation | 0.37311734 |
136 | MP0006138_congestive_heart_failure | 0.37179295 |
137 | MP0005174_abnormal_tail_pigmentation | 0.34033799 |
138 | MP0001881_abnormal_mammary_gland | 0.33278930 |
139 | MP0004858_abnormal_nervous_system | 0.32219501 |
140 | MP0003119_abnormal_digestive_system | 0.31394048 |
141 | MP0003638_abnormal_response/metabolism_ | 0.31056681 |
142 | MP0001845_abnormal_inflammatory_respons | 0.28915517 |
143 | MP0000427_abnormal_hair_cycle | 0.27192380 |
144 | MP0003091_abnormal_cell_migration | 0.27159324 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 8.98248739 |
2 | Ileus (HP:0002595) | 7.95985289 |
3 | Hydroxyprolinuria (HP:0003080) | 6.47505558 |
4 | Abnormality of proline metabolism (HP:0010907) | 6.47505558 |
5 | Right ventricular cardiomyopathy (HP:0011663) | 6.23241671 |
6 | Malnutrition (HP:0004395) | 5.71303572 |
7 | Acanthocytosis (HP:0001927) | 5.66725089 |
8 | Hypobetalipoproteinemia (HP:0003563) | 5.28536337 |
9 | Chronic diarrhea (HP:0002028) | 4.86196078 |
10 | Fat malabsorption (HP:0002630) | 4.80853391 |
11 | Conjugated hyperbilirubinemia (HP:0002908) | 4.57654401 |
12 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.90643216 |
13 | Hyperglycinuria (HP:0003108) | 3.83985585 |
14 | Systemic lupus erythematosus (HP:0002725) | 3.81532674 |
15 | Nausea (HP:0002018) | 3.72100749 |
16 | Poikilocytosis (HP:0004447) | 3.68662170 |
17 | Goiter (HP:0000853) | 3.68516316 |
18 | Autoimmune thrombocytopenia (HP:0001973) | 3.66483777 |
19 | Abnormality of vitamin B metabolism (HP:0004340) | 3.64064879 |
20 | Confusion (HP:0001289) | 3.61820686 |
21 | Wide cranial sutures (HP:0010537) | 3.58657203 |
22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.55033950 |
23 | Abdominal distention (HP:0003270) | 3.46683441 |
24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.36622372 |
25 | Hypolipoproteinemia (HP:0010981) | 3.30910854 |
26 | Myopathic facies (HP:0002058) | 3.26175345 |
27 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.21908917 |
28 | Gastrointestinal dysmotility (HP:0002579) | 3.16259337 |
29 | Abnormality of vitamin metabolism (HP:0100508) | 3.07140088 |
30 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.06975091 |
31 | Nephrolithiasis (HP:0000787) | 3.03704152 |
32 | Cupped ribs (HP:0000887) | 2.97124784 |
33 | Intrahepatic cholestasis (HP:0001406) | 2.96206491 |
34 | Pigmentary retinal degeneration (HP:0001146) | 2.95994435 |
35 | Progressive sensorineural hearing impairment (HP:0000408) | 2.93589806 |
36 | Hypophosphatemia (HP:0002148) | 2.92875475 |
37 | Proximal tubulopathy (HP:0000114) | 2.92011109 |
38 | Increased purine levels (HP:0004368) | 2.90990474 |
39 | Hyperuricemia (HP:0002149) | 2.90990474 |
40 | Flat acetabular roof (HP:0003180) | 2.88221625 |
41 | Increased mean platelet volume (HP:0011877) | 2.88097685 |
42 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.85547606 |
43 | Villous atrophy (HP:0011473) | 2.85547606 |
44 | Pustule (HP:0200039) | 2.79403606 |
45 | Metabolic alkalosis (HP:0200114) | 2.76651300 |
46 | Eczematoid dermatitis (HP:0000976) | 2.75886884 |
47 | Milia (HP:0001056) | 2.70668105 |
48 | Hypercholesterolemia (HP:0003124) | 2.70169587 |
49 | Reticulocytosis (HP:0001923) | 2.69167951 |
50 | Posterior subcapsular cataract (HP:0007787) | 2.65692789 |
51 | Decreased circulating renin level (HP:0003351) | 2.62979602 |
52 | Widely patent fontanelles and sutures (HP:0004492) | 2.60501188 |
53 | Abnormality of glycine metabolism (HP:0010895) | 2.60310358 |
54 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.60310358 |
55 | Alkalosis (HP:0001948) | 2.59733807 |
56 | Abnormal urine phosphate concentration (HP:0012599) | 2.59125368 |
57 | Syncope (HP:0001279) | 2.58653615 |
58 | Megaloblastic anemia (HP:0001889) | 2.58643212 |
59 | Hyperparathyroidism (HP:0000843) | 2.55986584 |
60 | Abnormal platelet volume (HP:0011876) | 2.52315436 |
61 | Abnormality of the gastric mucosa (HP:0004295) | 2.51780411 |
62 | Progressive hearing impairment (HP:0001730) | 2.50433856 |
63 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.49886222 |
64 | Tongue fasciculations (HP:0001308) | 2.48276636 |
65 | Autoimmune hemolytic anemia (HP:0001890) | 2.46810160 |
66 | Palpitations (HP:0001962) | 2.45001524 |
67 | Facial diplegia (HP:0001349) | 2.44981425 |
68 | Enlarged epiphyses (HP:0010580) | 2.44873078 |
69 | Hyperammonemia (HP:0001987) | 2.43486871 |
70 | Woolly hair (HP:0002224) | 2.40529805 |
71 | Hyperphosphaturia (HP:0003109) | 2.37996145 |
72 | Hemorrhage of the eye (HP:0011885) | 2.35116588 |
73 | Abnormal biliary tract morphology (HP:0012440) | 2.34558361 |
74 | Cerebral palsy (HP:0100021) | 2.34306915 |
75 | Alopecia of scalp (HP:0002293) | 2.32931949 |
76 | Xanthomatosis (HP:0000991) | 2.32173805 |
77 | Dicarboxylic aciduria (HP:0003215) | 2.31750283 |
78 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.31750283 |
79 | Petechiae (HP:0000967) | 2.30068257 |
80 | Steatorrhea (HP:0002570) | 2.28976667 |
81 | Micronodular cirrhosis (HP:0001413) | 2.28677835 |
82 | Delayed epiphyseal ossification (HP:0002663) | 2.27641784 |
83 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.27118711 |
84 | Hyperactive renin-angiotensin system (HP:0000841) | 2.25007289 |
85 | Dehydration (HP:0001944) | 2.23916924 |
86 | Epidermoid cyst (HP:0200040) | 2.23069414 |
87 | Metabolic acidosis (HP:0001942) | 2.22991874 |
88 | Muscle fibrillation (HP:0010546) | 2.22572642 |
89 | Agammaglobulinemia (HP:0004432) | 2.21346323 |
90 | Abnormality of purine metabolism (HP:0004352) | 2.19692411 |
91 | Abnormality of the costochondral junction (HP:0000919) | 2.17824824 |
92 | Hypotension (HP:0002615) | 2.17645279 |
93 | Pili torti (HP:0003777) | 2.16425140 |
94 | Pancreatitis (HP:0001733) | 2.14633783 |
95 | Hand muscle atrophy (HP:0009130) | 2.11925807 |
96 | Skin rash (HP:0000988) | 2.10986204 |
97 | Rectal prolapse (HP:0002035) | 2.08241740 |
98 | Encephalitis (HP:0002383) | 2.05896898 |
99 | Abnormality of renin-angiotensin system (HP:0000847) | 2.02651015 |
100 | Fragile nails (HP:0001808) | 2.01927060 |
101 | Congenital sensorineural hearing impairment (HP:0008527) | 2.01247535 |
102 | Abnormality of the 1st metacarpal (HP:0010009) | 1.97413548 |
103 | Gout (HP:0001997) | 1.97021160 |
104 | Late onset (HP:0003584) | 1.96175782 |
105 | Mesangial abnormality (HP:0001966) | 1.95160759 |
106 | Fragile skin (HP:0001030) | 1.94563527 |
107 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.93937114 |
108 | Biliary tract neoplasm (HP:0100574) | 1.93236992 |
109 | Paresthesia (HP:0003401) | 1.92854706 |
110 | Protuberant abdomen (HP:0001538) | 1.92244108 |
111 | Focal segmental glomerulosclerosis (HP:0000097) | 1.91884157 |
112 | Gingivitis (HP:0000230) | 1.91861800 |
113 | Abnormality of T cell physiology (HP:0011840) | 1.91361005 |
114 | Vasculitis (HP:0002633) | 1.90832489 |
115 | Atrophic scars (HP:0001075) | 1.90810396 |
116 | Abnormal albumin level (HP:0012116) | 1.90525430 |
117 | Hypoalbuminemia (HP:0003073) | 1.90525430 |
118 | Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318) | 1.89591925 |
119 | Polycythemia (HP:0001901) | 1.88820386 |
120 | Facial shape deformation (HP:0011334) | 1.88185269 |
121 | Potter facies (HP:0002009) | 1.88185269 |
122 | Growth hormone excess (HP:0000845) | 1.88041019 |
123 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.87973356 |
124 | Stridor (HP:0010307) | 1.86950654 |
125 | Bundle branch block (HP:0011710) | 1.86333240 |
126 | Renal tubular acidosis (HP:0001947) | 1.85931802 |
127 | Subcapsular cataract (HP:0000523) | 1.85421565 |
128 | Hoarse voice (HP:0001609) | 1.84505950 |
129 | Abnormal glucose tolerance (HP:0001952) | 1.84256603 |
130 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.84137981 |
131 | Hyperphosphatemia (HP:0002905) | 1.82596698 |
132 | Ventricular tachycardia (HP:0004756) | 1.81887705 |
133 | Amyloidosis (HP:0011034) | 1.81467123 |
134 | Abnormality of B cell number (HP:0010975) | 1.81201231 |
135 | Curly hair (HP:0002212) | 1.80891001 |
136 | Ventricular fibrillation (HP:0001663) | 1.80763891 |
137 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.80668133 |
138 | Abnormality of urine glucose concentration (HP:0011016) | 1.80095473 |
139 | Glycosuria (HP:0003076) | 1.80095473 |
140 | Gastrointestinal stroma tumor (HP:0100723) | 1.78777528 |
141 | Abnormality of nucleobase metabolism (HP:0010932) | 1.77428008 |
142 | Thin bony cortex (HP:0002753) | 1.77410083 |
143 | Lethargy (HP:0001254) | 1.77036628 |
144 | Increased IgE level (HP:0003212) | 1.75690202 |
145 | Diaphragmatic weakness (HP:0009113) | 1.75508560 |
146 | Complement deficiency (HP:0004431) | 1.74845908 |
147 | Polygenic inheritance (HP:0010982) | 1.73909776 |
148 | Abnormality of complement system (HP:0005339) | 1.73794446 |
149 | Distal upper limb amyotrophy (HP:0007149) | 1.72690217 |
150 | Upper limb amyotrophy (HP:0009129) | 1.72690217 |
151 | Macrocytic anemia (HP:0001972) | 1.71861805 |
152 | Chronic obstructive pulmonary disease (HP:0006510) | 1.71157149 |
153 | Obstructive lung disease (HP:0006536) | 1.71157149 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ACVR1B | 6.61532903 |
2 | MST4 | 5.97199306 |
3 | FRK | 5.77451974 |
4 | MST1R | 3.94911618 |
5 | NME1 | 3.69268821 |
6 | LMTK2 | 3.64907674 |
7 | GRK6 | 3.62146491 |
8 | AKT3 | 3.50643968 |
9 | RIPK1 | 2.98306452 |
10 | PRKG2 | 2.85011762 |
11 | EPHA2 | 2.65341605 |
12 | MAP2K2 | 2.64030253 |
13 | PTK6 | 2.61085931 |
14 | MAP3K10 | 2.45023445 |
15 | ERN1 | 2.08361609 |
16 | MAP3K2 | 1.99889547 |
17 | KDR | 1.85089891 |
18 | EPHB2 | 1.76305222 |
19 | STK10 | 1.64382301 |
20 | TESK1 | 1.56328783 |
21 | MET | 1.50857448 |
22 | TAOK1 | 1.46470358 |
23 | KIT | 1.42933324 |
24 | TESK2 | 1.40630353 |
25 | KSR2 | 1.32850323 |
26 | EPHB1 | 1.26996976 |
27 | CDK19 | 1.21821641 |
28 | PRKCI | 1.19897668 |
29 | PAK4 | 1.19702160 |
30 | PTK2 | 1.19293847 |
31 | PIK3CA | 1.18883200 |
32 | BTK | 1.16378144 |
33 | MYLK | 1.15610758 |
34 | CSF1R | 1.15212575 |
35 | PRPF4B | 1.13616884 |
36 | FES | 1.13198001 |
37 | DDR2 | 1.10800712 |
38 | FER | 1.06500332 |
39 | RIPK4 | 1.05584023 |
40 | MATK | 1.05465262 |
41 | MAP3K8 | 1.03561671 |
42 | OXSR1 | 1.02194250 |
43 | TTK | 1.01381323 |
44 | IKBKE | 1.01068730 |
45 | TEC | 1.00837989 |
46 | ERBB2 | 1.00659274 |
47 | TXK | 0.99921032 |
48 | SYK | 0.98584902 |
49 | MAP3K7 | 0.97166726 |
50 | MAP3K11 | 0.96401187 |
51 | BMX | 0.95777451 |
52 | MAP2K1 | 0.94519426 |
53 | BMPR2 | 0.91786624 |
54 | ZAP70 | 0.90869336 |
55 | SCYL2 | 0.88252450 |
56 | EPHA3 | 0.87656721 |
57 | NUAK1 | 0.85272994 |
58 | PIM1 | 0.84228285 |
59 | TNK2 | 0.82989333 |
60 | BCKDK | 0.82590723 |
61 | JAK3 | 0.80914981 |
62 | STK39 | 0.79617671 |
63 | DMPK | 0.79551983 |
64 | LCK | 0.79378672 |
65 | MAP2K6 | 0.78888967 |
66 | CDC42BPA | 0.78848316 |
67 | LRRK2 | 0.78538572 |
68 | NLK | 0.78019926 |
69 | LYN | 0.77814173 |
70 | PIK3CG | 0.75020296 |
71 | FGFR3 | 0.74650917 |
72 | LATS1 | 0.72816087 |
73 | MAPK11 | 0.72379158 |
74 | MAP3K1 | 0.71045064 |
75 | MAP3K9 | 0.70582548 |
76 | ICK | 0.70377878 |
77 | EPHA4 | 0.66367977 |
78 | PRKAA2 | 0.65382167 |
79 | IRAK4 | 0.63158192 |
80 | PAK3 | 0.63078035 |
81 | JAK1 | 0.61814896 |
82 | TAOK3 | 0.61737120 |
83 | MAP2K3 | 0.58994893 |
84 | MAP3K14 | 0.52240106 |
85 | TNIK | 0.50109872 |
86 | LIMK1 | 0.49493156 |
87 | ABL2 | 0.49166156 |
88 | HCK | 0.48646657 |
89 | RET | 0.46941935 |
90 | GRK1 | 0.45596671 |
91 | MAP3K12 | 0.45224817 |
92 | CAMK2D | 0.44809303 |
93 | MAP4K1 | 0.44470503 |
94 | STK3 | 0.44396200 |
95 | PDPK1 | 0.42212015 |
96 | IKBKB | 0.41593620 |
97 | TBK1 | 0.41359219 |
98 | CDK12 | 0.41263771 |
99 | CDK6 | 0.40808668 |
100 | AURKB | 0.40671201 |
101 | MAP3K5 | 0.40345808 |
102 | IRAK1 | 0.39633199 |
103 | PKN2 | 0.38428826 |
104 | SRC | 0.38034227 |
105 | EEF2K | 0.37979318 |
106 | BLK | 0.37330927 |
107 | PRKAA1 | 0.36756950 |
108 | MAPK7 | 0.36736297 |
109 | PAK1 | 0.35095775 |
110 | DAPK2 | 0.35027518 |
111 | PRKCZ | 0.33583685 |
112 | PRKCD | 0.31859787 |
113 | PDK1 | 0.31416733 |
114 | CSK | 0.29863187 |
115 | PDGFRA | 0.29587696 |
116 | DYRK1B | 0.28413808 |
117 | TYK2 | 0.28264285 |
118 | PAK2 | 0.28176590 |
119 | FGR | 0.27104903 |
120 | CAMK2B | 0.26784610 |
121 | ITK | 0.26060831 |
122 | PDK2 | 0.25732381 |
123 | PRKCA | 0.25716481 |
124 | MAP3K3 | 0.25659576 |
125 | FYN | 0.23939407 |
126 | ROCK1 | 0.23291121 |
127 | MAPKAPK2 | 0.22500623 |
128 | PRKACG | 0.22043487 |
129 | CAMK2G | 0.21884751 |
130 | AKT2 | 0.19121110 |
131 | MAP3K6 | 0.18990539 |
132 | PBK | 0.18667761 |
133 | TYRO3 | 0.18330853 |
134 | FGFR4 | 0.17779174 |
135 | CSNK1A1 | 0.17456119 |
136 | CDK5 | 0.17058460 |
137 | STK11 | 0.16924947 |
138 | PIM2 | 0.15291169 |
139 | PRKCQ | 0.15032125 |
140 | TRIB3 | 0.14207061 |
141 | JAK2 | 0.12969168 |
142 | ROCK2 | 0.12718397 |
143 | ALK | 0.11752658 |
144 | GSK3A | 0.11642828 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 5.90243672 |
2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 5.44080689 |
3 | Renin-angiotensin system_Homo sapiens_hsa04614 | 5.28249454 |
4 | Mineral absorption_Homo sapiens_hsa04978 | 3.87153055 |
5 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.60303330 |
6 | Bile secretion_Homo sapiens_hsa04976 | 2.95664109 |
7 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.89356016 |
8 | Histidine metabolism_Homo sapiens_hsa00340 | 2.41167188 |
9 | Galactose metabolism_Homo sapiens_hsa00052 | 2.36688920 |
10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.30442547 |
11 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.27641627 |
12 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.14060324 |
13 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.07008399 |
14 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.90230596 |
15 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.85304690 |
16 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.82439897 |
17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.80280286 |
18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.71105293 |
19 | Retinol metabolism_Homo sapiens_hsa00830 | 1.67616215 |
20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.65184824 |
21 | Asthma_Homo sapiens_hsa05310 | 1.64542957 |
22 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.61486129 |
23 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.58378253 |
24 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.52962768 |
25 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.49733036 |
26 | Allograft rejection_Homo sapiens_hsa05330 | 1.46406450 |
27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.40317024 |
28 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.37613228 |
29 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.34829531 |
30 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.34069120 |
31 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.33243242 |
32 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.27975118 |
33 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.26339161 |
34 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.19833484 |
35 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.15209013 |
36 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.14735491 |
37 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.12346612 |
38 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.07992384 |
39 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.04513200 |
40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.01076558 |
41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.97536101 |
42 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.95229320 |
43 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.92613908 |
44 | Tight junction_Homo sapiens_hsa04530 | 0.90004818 |
45 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.89579375 |
46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.81519536 |
47 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.79381428 |
48 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.79107142 |
49 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77932953 |
50 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.77045867 |
51 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.76233453 |
52 | ABC transporters_Homo sapiens_hsa02010 | 0.75040997 |
53 | Other glycan degradation_Homo sapiens_hsa00511 | 0.71810743 |
54 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.69193902 |
55 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.68909281 |
56 | Leishmaniasis_Homo sapiens_hsa05140 | 0.68654731 |
57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.67937884 |
58 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.65081530 |
59 | Peroxisome_Homo sapiens_hsa04146 | 0.62217435 |
60 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.60471283 |
61 | Salmonella infection_Homo sapiens_hsa05132 | 0.56997531 |
62 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.56788372 |
63 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.55491833 |
64 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.55423731 |
65 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54929115 |
66 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.53199149 |
67 | Adherens junction_Homo sapiens_hsa04520 | 0.52741629 |
68 | Carbon metabolism_Homo sapiens_hsa01200 | 0.51578044 |
69 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.51051550 |
70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49632607 |
71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43529859 |
72 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42666875 |
73 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42397465 |
74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42001806 |
75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41953275 |
76 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.41613366 |
77 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40642364 |
78 | Sulfur relay system_Homo sapiens_hsa04122 | 0.38735896 |
79 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.38594110 |
80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38552349 |
81 | Hepatitis C_Homo sapiens_hsa05160 | 0.36226631 |
82 | Viral myocarditis_Homo sapiens_hsa05416 | 0.36099327 |
83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34966643 |
84 | Thyroid cancer_Homo sapiens_hsa05216 | 0.34823585 |
85 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.34637199 |
86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32639760 |
87 | Bladder cancer_Homo sapiens_hsa05219 | 0.32201915 |
88 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.29572546 |
89 | Lysine degradation_Homo sapiens_hsa00310 | 0.29040978 |
90 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.28341130 |
91 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.27644804 |
92 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.26808931 |
93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.26120086 |
94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.25161601 |
95 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.23589200 |
96 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.23222270 |
97 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.22430897 |
98 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.21062447 |
99 | Insulin secretion_Homo sapiens_hsa04911 | 0.20677135 |
100 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.20342787 |
101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.20232114 |
102 | Long-term depression_Homo sapiens_hsa04730 | 0.20002953 |
103 | Salivary secretion_Homo sapiens_hsa04970 | 0.19014724 |
104 | Renin secretion_Homo sapiens_hsa04924 | 0.17786230 |
105 | Tuberculosis_Homo sapiens_hsa05152 | 0.17675356 |
106 | Gap junction_Homo sapiens_hsa04540 | 0.17367555 |
107 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.16965131 |
108 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.16809272 |
109 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.16591166 |
110 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.16490774 |
111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.16183051 |
112 | Influenza A_Homo sapiens_hsa05164 | 0.15507379 |
113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15412035 |
114 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.15387596 |
115 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.14422406 |
116 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.13987338 |
117 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.13373630 |
118 | Cocaine addiction_Homo sapiens_hsa05030 | 0.13282222 |
119 | Insulin resistance_Homo sapiens_hsa04931 | 0.12667556 |
120 | Amoebiasis_Homo sapiens_hsa05146 | 0.11919957 |
121 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.10921462 |
122 | Metabolic pathways_Homo sapiens_hsa01100 | 0.10293530 |
123 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.09555893 |
124 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.09504556 |
125 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.08853016 |
126 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.08689681 |
127 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.08463737 |
128 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.08370093 |
129 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.08204888 |
130 | Pertussis_Homo sapiens_hsa05133 | 0.07453515 |
131 | Shigellosis_Homo sapiens_hsa05131 | 0.07110210 |
132 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.07025633 |
133 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.06687102 |
134 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.06244549 |
135 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.05886745 |
136 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.02994484 |
137 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.01768509 |